Nymox Pharmaceutical
NYMX
#10189
Rank
NZ$31.59 M
Marketcap
Country
NZ$0.35
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -NZ$3.79 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -NZ$11.3 Million, an increase over its 2021 earnings that were of -NZ$21.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$3.79 Million-66.46%
2022 -NZ$11.3 Million-47.71%
2021 -NZ$21.61 Million6.61%
2020 -NZ$20.27 Million-10.91%
2019 -NZ$22.75 Million24.24%
2018 -NZ$18.31 Million-20.03%
2017 -NZ$22.9 Million2.71%
2016 -NZ$22.29 Million-63.86%
2015 -NZ$61.68 Million674.44%
2014 -NZ$7.97 Million-6.11%
2013 -NZ$8.49 Million-35.66%
2012 -NZ$13.19 Million-20.76%
2011 -NZ$16.64 Million38.33%
2010 -NZ$12.03 Million35.59%
2009 -NZ$8.88 Million11.8%
2008 -NZ$7.94 Million-12.94%
2007 -NZ$9.12 Million8.85%
2006 -NZ$8.38 Million36.5%
2005 -NZ$6.14 Million-4.4%
2004 -NZ$6.42 Million-14.58%
2003 -NZ$7.52 Million
2001 -NZ$5.52 Million-20.54%
2000 -NZ$6.94 Million21.72%
1999 -NZ$5.7 Million-25.56%
1998 -NZ$7.66 Million101.3%
1997 -NZ$3.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
NZ$14.08 B-376,684.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.51 B-548,549.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$2.22 B-59,655.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.95 B-1,041,451.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$56.07 B-1,499,220.78%๐Ÿ‡บ๐Ÿ‡ธ USA